Porsbjerg, Celeste M.Menzies-Gow, AndrewTran, Trung NMurray, Ruth BUnni, BindhuAng, Shi Ling AudreyAlacqua, MariannaAl-Ahmad, MonaAl-Lehebi, RiyadAltraja, AlanBelevskiy, Andrey S.Björnsdóttir, Unnur S.Bourdin, ArnaudBusby, JohnWalter Canonica, GChristoff, GeorgeCosio, Borja G.Costello, Richard WFitzGerald, J. MarkFonseca, João A.Hansen, SusanneHeaney, Liam GHeffler, EnricoHew, MarkIwanaga, TakashiJackson, David JKocks, Janwillem W HKallieri, MariaBruce Ko, Hsin-KuoSiyue, Mariko KohLarenas-Linnemann, DésiréeLehtimäki, Lauri A.Loukides, SteliosLugogo, NjiraMaspero, Jorge FPapaioannou, Andriana I.Perez de Llano, LuisMárcio Pitrez , PauloPopov, Todor ARasmussen, Linda M.Rhee, Chin KookSadatsafavi, MohsenSchmidt, JohannesSiddiqui, SalmanTaillé, CamilleTaube, ChristianTorres-Duque, Carlos A.Ulrik, CharlotteUpham, John WEileen, WangWechsler, Michael EBulathsinhala, LakminiCarter, VictoriaChaudhry, IshaEleangovan, NevaashniHosseini, NaeimehRowlands, Mari-AnnePrice, Davidvan Boven, Job FM2022-12-072022-12-072022-05Porsbjerg, C M, Menzies-Gow, A, Tran, T N, Murray, R B, Unni, B, Ang, S L A, Alacqua, M, Al-Ahmad, M, Al-Lehebi, R, Altraja, A, Belevskiy, A S, Björnsdóttir, U S, Bourdin, A, Busby, J, Walter Canonica, G, Christoff, G, Cosio, B G, Costello, R W, FitzGerald, J M, Fonseca, J A, Hansen, S, Heaney, L G, Heffler, E, Hew, M, Iwanaga, T, Jackson, D J, Kocks, J W H, Kallieri, M, Bruce Ko, H-K, Siyue, M K, Larenas-Linnemann, D, Lehtimäki, L A, Loukides, S, Lugogo, N, Maspero, J F, Papaioannou, A I, Perez de Llano, L, Márcio Pitrez , P, Popov, T A, Rasmussen, L M, Rhee, C K, Sadatsafavi, M, Schmidt, J, Siddiqui, S, Taillé, C, Taube, C, Torres-Duque, C A, Ulrik, C, Upham, J W, Eileen, W, Wechsler, M E, Bulathsinhala, L, Carter, V, Chaudhry, I, Eleangovan, N, Hosseini, N, Rowlands, M-A, Price, D & van Boven, J FM 2022, 'Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma', The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5. https://doi.org/10.1016/j.jaip.2021.12.0272213-2198https://hdl.handle.net/2164/19690Funding: This research study was funded and delivered by the Observational & Pragmatic Research Institute Pte Ltd (OPRI). The International Severe Asthma Registry is co-funded by Optimum Patient Care Global Limited and AstraZeneca.182127914021350engsevere asthmaBiologics accessBiologic eligibilityR MedicineSupplementary DataRJournal article10.1016/j.jaip.2021.12.027105